drugset / Trial / NCT01527968

Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty

NCT01527968

RandomizedParallel-groupDouble-blindTreatment

Summary

TXA and EACA have been reported to reduce blood loss in cardiac and neuro surgery, but there is no literature available comparing the two in total knee arthroplasty (TKA). The investigators want to determine if TXA or EACA compared with placebo are effective and safe for blood loss prevention in TKA by comparing blood loss, transfusion rates, and total cost.

Timeline

Start
2012-04
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aminocaproic Acid Small molecule 15 mg/kg Intravenous
Comparator Tranexamic Acid Small molecule 1 mg/kg

Indications